Open Payments

VALLEY CHILDRENS HOSPITAL

Type
Teaching hospital
Where
Madera, CA
Medicare CCN
053300
Received
$162,844 in 124 records, 2020 ($3,519 general, $159,325 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment16$3,519
2020Research payment108$159,325

By company

CompanyRecordsAmountYears
VERTEX PHARMACEUTICALS INCORPORATED2$64,1442020
Novo Nordisk AS74$26,2072020
ABBVIE INC.3$16,6262020
Abbott Laboratories10$16,4052020
Gilead Sciences, Inc.1$15,3002020
GENZYME CORPORATION4$9,4002020
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)3$9,1132020
Cochlear Americas8$2,1082020
Incyte Corporation10$1,1282020
Endo Pharmaceuticals Inc.1$1,0002020
KARL STORZ Endoscopy-America4$9212020
Vero Biotech Inc.1$2552020
Masimo Corporation2$1582020
Stryker Corporation1$752020

By nature of payment

NatureRecordsAmount
Research payment108$159,325
Grant8$2,108
Gift4$918
Food and Beverage1$255
Education3$237

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Masimo Corporation$91EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-31Stryker Corporation$75GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31Masimo Corporation$67EducationIn-kind items and servicesEMMA and ISA Device, Devices2020
2020-12-10Abbott Laboratories$1,000Research paymentCash or cash equivalentSJM Masters HP 15mm Rotatable Mechanical Heart Valve Device, Cardiac Arrhythmias and Heart FailureA Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as2020
2020-12-10Abbott Laboratories$500Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, Cardiac Arrhythmias and Heart FailureClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-12-10Abbott Laboratories$500Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, Cardiac Arrhythmias and Heart FailureClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-12-10Abbott Laboratories$255Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, Cardiac Arrhythmias and Heart FailureClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-11-12Abbott Laboratories$1,500Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, Cardiac Arrhythmias and Heart FailureClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-11-11Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$1,613Research paymentCash or cash equivalentZOLGENSMA Biological, GENE THERAPYA Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy2020
2020-11-09Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-11-09Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-11-09Incyte Corporation$10Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-11-09Incyte Corporation$0Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-11-05Vero Biotech Inc.$255Food and BeverageIn-kind items and servicesGenosyl Drug, Respiratory Therapy2020
2020-11-02Gilead Sciences, Inc.$15,300Research paymentCash or cash equivalentVeklury Drug, COVID-19A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesi2020
2020-10-21Abbott Laboratories$550Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, VascularClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-10-15Abbott Laboratories$500Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, VascularClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-08-25Novo Nordisk AS$2,000Research paymentCash or cash equivalentNN8640-42632020
2020-08-25Novo Nordisk AS$180Research paymentCash or cash equivalentNN8640-42632020
2020-08-18Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$6,500Research paymentCash or cash equivalentZOLGENSMA Biological, GENE THERAPYA Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy2020
2020-08-18Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$1,000Research paymentCash or cash equivalentZOLGENSMA Biological, GENE THERAPYA Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy2020
2020-08-17GENZYME CORPORATION$1,200Research paymentCash or cash equivalentHECTOROL Drug, Genetic DiseaseAn Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules)2020
2020-08-06Abbott Laboratories$7,000Research paymentCash or cash equivalentSJM Masters HP 15mm Rotatable Mechanical Heart Valve Device, Cardiac Arrhythmias and Heart FailureA Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as2020
2020-08-04GENZYME CORPORATION$4,500Research paymentCash or cash equivalentHECTOROL Drug, Genetic DiseaseAn Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules)2020
2020-08-04GENZYME CORPORATION$2,500Research paymentCash or cash equivalentHECTOROL Drug, Genetic DiseaseAn Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules)2020
2020-08-04GENZYME CORPORATION$1,200Research paymentCash or cash equivalentHECTOROL Drug, Genetic DiseaseAn Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules)2020
2020-07-22Abbott Laboratories$1,100Research paymentCash or cash equivalentAmplatzer Muscular VSD (MuVSD) Occluder Device, Cardiac Arrhythmias and Heart FailureClosure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval S2020
2020-06-30Cochlear Americas$185GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-06-22Cochlear Americas$97GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-06-04Abbott Laboratories$3,500Research paymentCash or cash equivalentSJM Masters HP 15mm Rotatable Mechanical Heart Valve Device, Cardiac Arrhythmias and Heart FailureA Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as2020
2020-04-27ABBVIE INC.$9,922Research paymentIn-kind items and servicesVENCLEXTA Drug, ONCOLOGYC19-9202020
2020-04-27ABBVIE INC.$3,375Research paymentIn-kind items and servicesVENCLEXTA Drug, ONCOLOGYC19-9202020
2020-04-27ABBVIE INC.$3,329Research paymentIn-kind items and servicesVENCLEXTA Drug, ONCOLOGYC19-9202020
2020-04-23Novo Nordisk AS$3,500Research paymentCash or cash equivalentNN8640-42632020
2020-03-31Novo Nordisk AS$6,000Research paymentCash or cash equivalentNN8640-42632020
2020-03-31Novo Nordisk AS$1,500Research paymentCash or cash equivalentNN8640-42632020
2020-03-31Novo Nordisk AS$500Research paymentCash or cash equivalentNN8640-42632020
2020-03-31Novo Nordisk AS$500Research paymentCash or cash equivalentNN8640-42632020
2020-03-11Cochlear Americas$650GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-03-11Cochlear Americas$425GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-03-11Cochlear Americas$300GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-03-11Cochlear Americas$200GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-03-11Cochlear Americas$154GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-03-11Cochlear Americas$97GrantIn-kind items and servicesNucleus Device, Implantable hearing solution2020
2020-02-15VERTEX PHARMACEUTICALS INCORPORATED$1,375Research paymentCash or cash equivalentA Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F)2020
2020-02-13Incyte Corporation$1,000Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-02-11Endo Pharmaceuticals Inc.$1,000Research paymentCash or cash equivalentSUPPRELIN Drug, ENDOCRINOLOGYA MULTICENTER, OBSERVATIONAL REGISTRY OF PEDIATRIC FEMALE PATIENTS WITH CENTRAL PRECOCIOUS PUBERTY REVCEIVING SUPPRELIN 2020
2020-02-10KARL STORZ Endoscopy-America$78EducationIn-kind items and servicesVIDEO-URETERO-RENOSCOPE FLEX XC Device, UROLOGY2020
2020-02-10Incyte Corporation$37Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-02-10Incyte Corporation$21Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-02-10Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-02-10Incyte Corporation$12Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-02-10Incyte Corporation$10Research paymentCash or cash equivalentA Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tub2020
2020-01-22Novo Nordisk AS$10,000Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$831Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$250Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$250Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$150Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$17Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$9Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$7Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$6Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$3Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$1Research paymentIn-kind items and servicesNN8640-42632020
2020-01-22Novo Nordisk AS$1Research paymentIn-kind items and servicesNN8640-42632020
2020-01-13KARL STORZ Endoscopy-America$468GiftIn-kind items and services2020
2020-01-13KARL STORZ Endoscopy-America$257GiftIn-kind items and services2020
2020-01-13KARL STORZ Endoscopy-America$117GiftIn-kind items and services2020
2020-01-01VERTEX PHARMACEUTICALS INCORPORATED$62,769Research paymentCash or cash equivalentA Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy2020

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Madera CountyMadera city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Madera, CA, county Madera County, CA, state California; placed by its city name.

MeasurePlace (city or town)
Madera, CA
County
Madera County, CA
State
California
Population B0100367,831160,94039,287,377
Population, 2020 census P166,224156,25539,538,223
Median age B0100230.434.637.9
Under 18 B0100130.8%27.1%22.0%
65 and over B010019.6%14.4%15.7%
Households B1100117,52645,37913,548,091
Foreign born B0500225.6%20.1%27.0%
Median household income B19013$63,933$76,627$99,122
Median family income B19113$67,479$83,389$113,346
Per capita income B19301$24,200$30,077$49,513
Poverty rate B1700125.6%19.2%12.0%
Unemployment rate B2302512.6%10.1%6.6%
Civilian labor force B2302529,99769,01220,068,466
Mean commute (minutes) B0801325.727.928.7
Bachelor's degree or higher B1500310.9%17.9%37.1%
Housing units B2500118,56251,01514,644,735
Owner-occupied B2500354.7%67.5%55.9%
Renters B2500345.3%32.5%44.1%
Median home value B25077$359,900$393,200$734,700
Median gross rent B25064$1,353$1,390$2,036
White, not Hispanic B0300212.2%29.9%33.8%
Black B030022.9%2.4%5.2%
Hispanic or Latino B0300281.1%60.9%40.2%
Asian B030021.3%2.4%15.3%
American Indian and Alaska Native B030020.1%0.4%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Madera, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.